| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6199855 | Ophthalmology | 2016 | 11 Pages |
Abstract
According to our data, patients with UM can be classified into 3 groups, of which EIF1AX-mutated tumors and tumors without BAP1, SF3B1, or EIF1AX mutations are associated with prolonged survival and low metastatic risk, SF3B1-mutated tumors are associated with late metastasis, and tumors with an aberrant BAP1 are associated with an early metastatic risk and rapid decline in patient DFS.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Serdar MD, Anna E. MD, PhD, Robert M. MD, PhD, Jolanda BSc, Bert BSc, Alice BSc, Dion MD, PhD, Emine MD, PhD, Annelies PhD, Rotterdam Ocular Melanoma Study Group Rotterdam Ocular Melanoma Study Group,